Drug adverse event reports (FAERS)

Aphasia, Immunodeficiency

Drugs: STEM CELL, EXOSOME, GROWTH FACTOR OR TISSUE DERIVED UNAPPROVED PRODUCT

SeriousDisabilityOther seriousReport 26309431
Safetyreportversion
1
Safetyreportid
26309431
Primarysourcecountry
US
Transmissiondateformat
102
Transmissiondate
20260415
Reporttype
1
Serious
1
Seriousnessdeath
2
Seriousnesslifethreatening
2
Seriousnesshospitalization
2
Seriousnessdisabling
1
Seriousnesscongenitalanomali
2
Seriousnessother
1
Receivedateformat
102
Receivedate
20260125
Receiptdateformat
102
Receiptdate
20260125
Fulfillexpeditecriteria
3
Authoritynumb
FDA-CDER-CTU-2026-4913
Primarysource
Reportercountry
US
Qualification
5
Sender
Sendertype
6
Senderorganization
FDA-CTU
Receiver
Receivertype
6
Receiverorganization
FDA
Patient
Patientonsetage
60
Patientonsetageunit
801
Patientweight
69.4
Patientsex
2
Reaction
  1. Reactionmeddraversionpt
    28.1
    Reactionmeddrapt
    Aphasia
  2. Reactionmeddraversionpt
    28.1
    Reactionmeddrapt
    Immunodeficiency
Drug
  1. Drugcharacterization
    1
    Medicinalproduct
    STEM CELL, EXOSOME, GROWTH FACTOR OR TISSUE DERIVED UNAPPROVED PRODUCT
    Drugadditional
    2
    Activesubstance
    Activesubstancename
    STEM CELL, EXOSOME, GROWTH FACTOR OR TISSUE DERIVED UNAPPROVED PRODUCTS
Summary
Narrativeincludeclinical
CASE EVENT DATE: 20250501
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Join as a DoctorSell on MedGrid

How to read this: Each report says someone told FDA an event happened while a product was used. A report does not show the product caused it, and counts rise and fall with how many people report. Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.